Falk Gastro Review Journal

Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

The latest issues

Edition 3/2024

Edition 2/2024

Edition 1/2024

Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

All articles

The environmental impact of gastrointestinal procedures: A prospective study of waste generation, energy consumption, and auditing in an endoscopy unit

Gastroenterology. 2024;166(3):496–502.e3

Reducing scope 3 carbon emissions in gastrointestinal endoscopy: Results of the prospective study of the ‘Green Endoscopy Project Würzburg’

Gut. 2024;73(3):442–7

Endoscopic ultrasonography-guided gastroenterostomy versus uncovered duodenal metal stenting for unresectable malignant gastric outlet obstruction (DRA-GOO): A multicenter randomized controlled trial

Lancet Gastroenterol Hepatol. 2024;9(2):124–32

Evolution of symptoms after ustekinumab induction therapy in patients with Crohn’s disease

Clin Gastroenterol Hepatol. 2024;22(1):144–53.e2

Efficacy and safety of 48 weeks of guselkumab for patients with Crohn’s disease: Maintenance results from the phase 2, randomized, double-blind GALAXI-1 trial

Lancet Gastroenterol Hepatol. 2024;9(2):133–46

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn’s disease (PROFILE): A multicenter, open-label randomized controlled trial

Lancet Gastroenterol Hepatol. 2024;9(5):415–27

Tumor necrosis factor inhibitors in inflammatory bowel disease and risk of immune-mediated inflammatory diseases

Clin Gastroenterol Hepatol. 2024;22(1):135–43.e8

Proton-pump inhibitors and risk of enteric infection in inflammatory bowel disease: A self-controlled case series

Inflamm Bowel Dis. 2024;30(1):38–44

Absolute and relative risks of kidney and urological complications in patients with inflammatory bowel disease

Am J Gastroenterol. 2024;119(1):138–46